Depression News and Research

Latest Depression News and Research

Rexahn Pharmaceuticals' Phase IIa clinical results of Serdaxin for MDD: Additional insights

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing potential best in class oncology and central nervous system (CNS) therapeutics, today offered additional commentary, clarifications and insights on yesterday's announcement of its Phase IIa clinical results of Serdaxin® in the treatment of major depressive disorder (MDD).

15 Apr 2010

Fathers of sexually abused children suffer from anxiety, grief and depression, says study

The preliminary results of a Universit- de Montr-al study show that fathers of sexually abused children can suffer from anxiety, depression and grief. Such patriarchs are often overwhelmed by a desire for vengeance, yet little literature exists to help them deal with their pain.

15 Apr 2010

Combivent Inhalation Aerosol's "essential use" status effective through 2013

Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced that the U.S. Food and Drug Administration (FDA) has determined that the "essential use" status of Combivent® (ipratropium bromide and albuterol sulfate) Inhalation Aerosol will be effective through December 31, 2013. With this ruling, COMBIVENT will remain on the market and available to the more than two million chronic obstructive pulmonary disease (COPD) patients who rely on it as a bronchodilator.

15 Apr 2010

Phase IIa clinical trial results of Serdaxin for treatment of MDD

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing potential best in class oncology and central nervous system therapeutics, today announced clinical results with its investigational new drug, Serdaxin®for the treatment of major depressive disorder.

15 Apr 2010

Parents' wartime deployment can have an impact on children’s behavioral problems

The current conflicts in Iraq and Afghanistan have resulted in extended and repeated combat-related deployments of U.S. military service members. While much has been reported about the problems, both physical and psychological, many bring back with them, new research out of UCLA shows that the family back home can have issues as well.

15 Apr 2010

Epilepsy patients who take Ginkgo products face increased risk of seizures: Report

Restrictions should be placed on the use of Ginkgo biloba - a top-selling herbal remedy - because of growing scientific evidence that Ginkgo may increase the risk of seizures in people with epilepsy and could reduce the effectiveness of anti-seizure drugs, a new report concludes. The article appears in ACS' monthly Journal of Natural Products.

15 Apr 2010

Family support critical for managing patients with chronic health problems

Almost 40 percent of chronically ill older adults in the U.S. live alone, and a majority of those who are married have spouses with at least one chronic illness that can affect their ability to provide support, according to a U-M study published in the journal Chronic Illness.

15 Apr 2010

Anticonvulsants increase suicide risk

Dr. Elisabetta Patorno, a research fellow at Brigham and Women's Hospital and Harvard Medical School in Boston has published a study this week in the Journal of American Medical Association which found that taking anticonvulsant drugs raise thoughts of suicide and risks of actually trying to commit suicide by two times the norm. The study was sponsored by the Harvard School of Public Health and HealthCore, a research subsidiary of WellPoint. WellPoint is a health benefits company that serves the Blue Cross Blue Shield network.

14 Apr 2010

Spare the rod – kids spanked more likely to be aggressive

As the saying goes, “spare the rod and spoil the child”. Many organizations including American Academy of Pediatrics and the American Psychological Association have found that this is a wrong statement and spanking a child may do more harm than good.

13 Apr 2010

Alkermes submits VIVITROL sNDA for opioid dependence

Alkermes, Inc. today announced that it has submitted a supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) to the U.S. Food and Drug Administration (FDA) for approval as a treatment for opioid dependence. The company requested a priority review for its sNDA and if granted by the FDA, it would mean a six month review timeline.

13 Apr 2010

New driving guideline for people with Alzheimer's disease

The American Academy of Neurology has issued a new guideline to help determine when people with Alzheimer's disease or another type of dementia should stop driving. The guideline is published in the April 12, 2010, online issue of Neurology, the medical journal of the American Academy of Neurology, and was presented at the American Academy of Neurology's Annual Meeting in Toronto.

13 Apr 2010

Health care professionals urge Congress to support nation's chemical regulatory reform

On the eve of legislation slated to be introduced this month to reform the Toxic Substances Control Act, almost two dozen organizations representing health care professionals, along with health sector businesses sent letters to Congress urging the passage of strong reform of our nation's chemical regulatory system.

13 Apr 2010

'Mindfulness' for reducing aggressive behaviour in people with developmental disabilities

A very ancient and effective practice - mindfulness - is being given a new and surprising application. For the first time ever, mindfulness is being used to reduce the likelihood of aggressive behaviour in people with developmental disabilities as well as mental health problems.

13 Apr 2010

SCAN Health Plan honors Monarch HealthCare of Orange County with Wave award

Monarch HealthCare of Orange County has been named this year's recipient of SCAN Health Plan's "Wave" award, presented annually to a medical group that combines "high levels of performance or improvement in the field of geriatrics" with a "strong commitment to care for seniors and SCAN members."

13 Apr 2010

New article focuses on the role of registered dietitians in patient management

More than one third of Americans are considered obese and approximately 15 million (5%) Americans now have a body mass index greater than 40. The April issue of the Journal of the American Dietetic Association focuses on the ever-increasing use of bariatric surgery to control the excess morbidity and mortality associated with extreme obesity and the important role that registered dietitians play in the management of patients who have undergone the procedure.

13 Apr 2010

Antidepressants and mood stabilizers may benefit stroke victims

A study in rodents shows the growth of new neurons, also known as neurogenesis, lessens the severity of stroke and dramatically improves function following a stroke. The research, undertaken at the Buck Institute for Age Research, suggests that drugs shown to promote neurogenesis in rodents could have benefits for human stroke victims and that those drugs-which include antidepressants and mood stabilizers such as lithium-may be suitable for study in human clinical trials.

13 Apr 2010

Study supports use of Fisher Wallace Cranial Stimulator for treating depression, anxiety and insomnia

Fisher Wallace Laboratories today announced the results of a brain stimulation study involving the Fisher Wallace Cranial Stimulator, a portable medical device that treats depression, anxiety and insomnia. The study, published in The Neuroscientist and authored by Dr. Felipe Fregni, assistant professor in neurology at Harvard Medical School, analyzes a decade's worth of research on the brain stimulation technology used by the Fisher Wallace Cranial Stimulator.

13 Apr 2010

Stress hormones may suppress tumor growth: Study

Chronic stress triggers a chain of molecular events that protects breakaway ovarian cancer cells from destruction, a team of researchers led by scientists at The University of Texas M. D. Anderson Cancer Center reports April 12 in the early online publication of the Journal of Clinical Investigation.

13 Apr 2010

Health care experts brand plan for a “Big Australia” as disaster waiting to happen

Increased immigration rates are set to make Australia’s population hit 36 million by the year 2050 according to Federal Government estimates. This would be a huge leap from the present 22,300,000 people that the nation has today. The added population is being seen as a necessity to ensure economical survival for the country.

13 Apr 2010

Maldonado Medical opens new location in Beverly Hills, California

Maldonado Medical LLC, one of the nation's largest out of network durable medical equipment providers, announces the opening of another California location in Beverly Hills.

13 Apr 2010

Depression News and Research

Latest Depression News and Research

Rexahn Pharmaceuticals' Phase IIa clinical results of Serdaxin for MDD: Additional insights

Fathers of sexually abused children suffer from anxiety, grief and depression, says study

Combivent Inhalation Aerosol's "essential use" status effective through 2013

Phase IIa clinical trial results of Serdaxin for treatment of MDD

Parents' wartime deployment can have an impact on children’s behavioral problems

Epilepsy patients who take Ginkgo products face increased risk of seizures: Report

Family support critical for managing patients with chronic health problems

Anticonvulsants increase suicide risk

Spare the rod – kids spanked more likely to be aggressive

Alkermes submits VIVITROL sNDA for opioid dependence

New driving guideline for people with Alzheimer's disease

Health care professionals urge Congress to support nation's chemical regulatory reform

'Mindfulness' for reducing aggressive behaviour in people with developmental disabilities

SCAN Health Plan honors Monarch HealthCare of Orange County with Wave award

New article focuses on the role of registered dietitians in patient management

Antidepressants and mood stabilizers may benefit stroke victims

Study supports use of Fisher Wallace Cranial Stimulator for treating depression, anxiety and insomnia

Stress hormones may suppress tumor growth: Study

Health care experts brand plan for a “Big Australia” as disaster waiting to happen

Maldonado Medical opens new location in Beverly Hills, California

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Depression News and Research

Latest Depression News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in